OBJECTIVE: Establish provider delay for breast cancer and related factors. MATERIAL AND METHODS: 1,106 women with breast cancer were approached in health care institutions of Bogota, Colombia. According to the history of first consultation, we established diagnostic and treatment incidence rates, which were compared for different variables. A Cox hazard model was established. RESULTS: Median time from first consultation to diagnosis and start of treatment were 91 days (CI95%:82-97 days) and 137 days (CI95%:127-147 days) respectively. Diagnosis and treatment were faster in women with higher educational level, affiliated to the "special" social security, with better socioeconomic conditions and in screening-detected breast cancers. CONCLUSION: Provider delay is excessive. There are clear inequities in access to services and a need of reducing the waiting times for women with a suspicion of breast cancer.
OBJECTIVE: Establish provider delay for breast cancer and related factors. MATERIAL AND METHODS: 1,106 women with breast cancer were approached in health care institutions of Bogota, Colombia. According to the history of first consultation, we established diagnostic and treatment incidence rates, which were compared for different variables. A Cox hazard model was established. RESULTS: Median time from first consultation to diagnosis and start of treatment were 91 days (CI95%:82-97 days) and 137 days (CI95%:127-147 days) respectively. Diagnosis and treatment were faster in women with higher educational level, affiliated to the "special" social security, with better socioeconomic conditions and in screening-detected breast cancers. CONCLUSION: Provider delay is excessive. There are clear inequities in access to services and a need of reducing the waiting times for women with a suspicion of breast cancer.
Authors: Esther de Vries; Ivan Arroyave; Constanza Pardo; Carolina Wiesner; Raul Murillo; David Forman; Alex Burdorf; Mauricio Avendaño Journal: J Epidemiol Community Health Date: 2014-12-09 Impact factor: 3.710
Authors: Carlos Duarte; Alejandro Salazar; Kathrin Strasser-Weippl; Esther de Vries; Carolina Wiesner; Angélica Arango-Gutiérrez; Lindsay Krush; Paul E Goss Journal: Breast Cancer Res Treat Date: 2021-02-21 Impact factor: 4.872
Authors: Joseph A Pinto; Luis Pinillos; Cynthia Villarreal-Garza; Zaida Morante; Manuel V Villarán; Gerson Mejía; Christian Caglevic; Alfredo Aguilar; Williams Fajardo; Franz Usuga; Marcia Carrasco; Pamela Rebaza; Ana M Posada; Indira Tirado-Hurtado; Claudio Flores; Carlos S Vallejos Journal: Ecancermedicalscience Date: 2019-01-22
Authors: Ignacio Briceño-Balcázar; Alberto Gómez-Gutiérrez; Natalia Andrea Díaz-Dussán; María Claudia Noguera-Santamaría; Diego Díaz-Rincón; María Consuelo Casas-Gómez Journal: Colomb Med (Cali) Date: 2017-06-30
Authors: Isabelle Soerjomataram; Joannie Lortet-Tieulent; Jacques Ferlay; David Forman; Colin Mathers; D Maxwell Parkin; Freddie Bray Journal: BMC Med Res Methodol Date: 2012-08-17 Impact factor: 4.615